Table 1 Clinical features of the HA-MRSA and CA-MRSA strains
Characteristic | CA-MRSA | HA-MRSA | P-value |
|---|---|---|---|
(n = 23) | (n = 39) | ||
n(%) | n(%) | ||
Sex | |||
 Male | 11(47.8) | 24(61.5) | 0.427 |
 Female | 12(52.2) | 15(38.5) | |
Age | |||
  ~ 18 | 5(21.7) | 3(7.7) | 0.149 |
 19-60 | 11(47.8) | 16(41.0) | |
  > 60 | 7(30.4) | 20(51.3) | |
Season | |||
 Mar. ~May | 9(39.1) | 1(2.6) | 0.001 |
 Jul. ~Aug. | 2(8.7) | 14(35.9) | |
 Sep. ~Nov. | 7(30.4) | 15(38.5) | |
 Dec. ~Feb. | 5(21.7) | 9(23.1) | |
Clinical source | |||
 Skin lesion | 15(65.2) | 16(41.0) | 0.001 |
 Pus | 5(21.7) | 1(2.6) | |
 Sputa | 2(8.7) | 22(56.4) | |
 Bone | 1(4.3) | 0(0) | |
Type of infection | |||
 Infection of skin and soft tissue | 20(87.0) | 11(28.2) | <0.001 |
 Pneumonia | 2(8.7) | 22(56.4) | |
 Infection of the surgical site | 0(0) | 6(15.4) | |
 Infection of bone and joint | 1(4.3) | 0(0) | |
Underline disease | |||
 None | 11(47.8) | 13(33.3) | 0.147 |
 Diabetes | 5(21.7) | 5(12.8) | |
 Hypertension | 6(26.1) | 9(23.1) | |
 Tumor | 0(0) | 4(10.3) | |
 Brain injury | 1(4.3) | 10(25.6) | |
 Other | 2(8.6) | 6(15.4) | |
Outcomes | |||
 Relapse | 5(21.7) | 9(23.1) | 0.809 |
 Improvement | 17(73.9) | 25(64.1) | |
 Death within 1 month | 1(49.4) | 3(7.7) | |